Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunwei Shen

Showing results (21-30 of 207) with videos related to

Pageof 21
Sort By:
Cancer Medicine|September 25, 2021
Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancerJin Hong, Weiwei Rui, Xiaochun Fei, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 18, 2014
[Treatment patterns and affecting factors in breast cancer patients over 65-years of age]Yan Mao, Xiaosong Chen, Weiqi Gao, et al.
Frontiers in Oncology|May 23, 2022
Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer PatientsYiwei Tong, Siyi Zhu, Weiguo Chen, et al.
Therapeutic Advances in Medical Oncology|March 19, 2021
Association between tumor molecular subtype, clinical stage and axillary pathological response in breast cancer patients undergoing complete pathological remission after neoadjuvant chemotherapy: potential implications for de-escalation of axillary surgeryJin Hong, Yiwei Tong, Jianrong He, et al.
Frontiers in Endocrinology|August 30, 2021
21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer PatientsYifei Zhu, Tiange Wang, Yiwei Tong, et al.
Journal of Medical Internet Research|September 16, 2021
A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational StudyJing Yu, Jiayi Wu, Ou Huang, et al.
International Journal of Molecular Sciences|May 11, 2024
Biological Roles and Clinical Applications of Exosomes in Breast Cancer: A Brief ReviewHan Wang, Ruo Wang, Kunwei Shen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 27, 2016
Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancerJunjun Liu, Xiaosong Chen, Toby Ward, et al.
Journal of Cancer|March 24, 2020
Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence ScoreWeiqi Gao, Lin Lin, Xiaochun Fei, et al.
Frontiers in Molecular Biosciences|November 6, 2023
Two-carbon tethered artemisinin-isatin hybrids: design, synthesis, anti-breast cancer potential, and <i>in silico</i> studyRuo Wang, Renhong Huang, Yaofeng Yuan, et al.
Pageof 21

Showing results (21-30 of 207) with videos related to

Sort By:
Pageof 21
Cancer Medicine|September 25, 2021
Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancerJin Hong, Weiwei Rui, Xiaochun Fei, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 18, 2014
[Treatment patterns and affecting factors in breast cancer patients over 65-years of age]Yan Mao, Xiaosong Chen, Weiqi Gao, et al.
Frontiers in Oncology|May 23, 2022
Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer PatientsYiwei Tong, Siyi Zhu, Weiguo Chen, et al.
Therapeutic Advances in Medical Oncology|March 19, 2021
Association between tumor molecular subtype, clinical stage and axillary pathological response in breast cancer patients undergoing complete pathological remission after neoadjuvant chemotherapy: potential implications for de-escalation of axillary surgeryJin Hong, Yiwei Tong, Jianrong He, et al.
Frontiers in Endocrinology|August 30, 2021
21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer PatientsYifei Zhu, Tiange Wang, Yiwei Tong, et al.
Journal of Medical Internet Research|September 16, 2021
A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational StudyJing Yu, Jiayi Wu, Ou Huang, et al.
International Journal of Molecular Sciences|May 11, 2024
Biological Roles and Clinical Applications of Exosomes in Breast Cancer: A Brief ReviewHan Wang, Ruo Wang, Kunwei Shen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 27, 2016
Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancerJunjun Liu, Xiaosong Chen, Toby Ward, et al.
Journal of Cancer|March 24, 2020
Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence ScoreWeiqi Gao, Lin Lin, Xiaochun Fei, et al.
Frontiers in Molecular Biosciences|November 6, 2023
Two-carbon tethered artemisinin-isatin hybrids: design, synthesis, anti-breast cancer potential, and <i>in silico</i> studyRuo Wang, Renhong Huang, Yaofeng Yuan, et al.
Pageof 21